Inhibition of dendropoiesis by tumor derived and purified prostate specific antigen

Journal of Urology

Volumn 170, Issue 5, 2003, Pages 2026-2030

  Aalamian, Maryam ^a   Tourkova, Irina L ^b   Chatta, Gurkamal S ^b   Lilja, Hans ^c,d   Huland, Edith ^a   Huland, Hartwig ^a   Shurin, Galina V ^b   Shurin, Michael R ^b,e  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

^c LUND UNIVERSITY   (Sweden)

^d MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^e UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

Dendritic cells; Immunosuppression; Prostate; Prostate specific antigen; Prostatic neoplasms

Indexed keywords

B7 ANTIGEN; CD83 ANTIGEN; CD86 ANTIGEN; HLA DR ANTIGEN; PROSTATE SPECIFIC ANTIGEN; SERINE PROTEINASE; TUMOR MARKER;

ANIMAL CELL; ANTIGEN PRESENTING CELL; ARTICLE; CANCER GROWTH; CELL MATURATION; CONTROLLED STUDY; DENDRITIC CELL; DENDROPOIESIS; DISEASE MARKER; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNE DEFICIENCY; IN VITRO STUDY; LYMPHOCYTE PROLIFERATION; MAJOR HISTOCOMPATIBILITY COMPLEX; MALE; MIXED LYMPHOCYTE REACTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROSTATE CANCER; T LYMPHOCYTE; TUMOR IMMUNITY;

EID: 0141954158     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ju.0000091264.46134.b7     Document Type: Article

References (20)

1. Stephan, C., Jung, K., Diamandis, E. P., Rittenhouse, H. G., Lein, M. and Loening, S. A.: Prostate-specific antigen, its molecular forms, and other kallikrein markers for detection of prostate cancer. Urology, 59: 2, 2002
2. Cramer, S. D., Chen, Z. and Peehl, D. M.: Prostate specific antigen cleaves parathyroid hormone-related protein in the PTH-like domain: inactivation of PTHrP-stimulated cAMP accumulation in mouse osteoblasts. J Urol, 156: 526, 1996
3. Cohen, P., Graves, H. C., Peehl, D. M., Kamarei, M., Giudice, L. C. and Rosenfeld, R. G.: Prostate-specific antigen (PSA) is an insulin-like growth factor binding protein-3 protease found in seminal plasma. J Clin Endocrinol Metab, 75: 1046, 1992
4. Yonou, H., Aoyagi, Y., Kanomata, N., Kamijo, T., Oda, T., Yokose, T. et al: Prostate-specific antigen induces osteoplastic changes by an autonomous mechanism. Biochem Biophys Res Commun, 289: 1082, 2001
5. Aalamian, M., Pirtskhalaishvili, G., Nunez, A., Esche, C., Shurin, G. V., Huland, E. et al: Human prostate cancer regulates generation and maturation of monocyte-derived dendritic cells. Prostate, 46: 68, 2001
6. Shurin, G. V., Aalamian, M., Pirtskhalaishvili, G., Bykovskaia, S., Huland, E., Huland, H. et al: Human prostate cancer blocks the generation of dendritic cells from CD34+ hematopoietic progenitors. Eur Urol, suppl., 39: 37, 2001
7. Lilja, H., Christensson, A., Dahlen, U., Matikainen, M. T., Nilsson, O., Pettersson, K. et al: Prostate-specific antigen in serum occurs predominantly in complex with alpha 1-antichymotrypsin. Clin Chem, 37: 1618, 1991
8. Pettersson, K., Piironen, T., Seppala, M., Liukkonen, L., Christensson, A., Matikainen, M. T. et al: Free and complexed prostate-specific antigen (PSA): in vitro stability, epitope map, and development of immunofluorometric assays for specific and sensitive detection of free PSA and PSA-alpha 1-antichymotrypsin complex. Clin Chem, 41: 1480, 1995
9. Lilja, H.: Regulation of the enzymatic activity of prostate-specific antigen and its reactions with extracellular protease inhibitors in prostate cancer. Scand J Clin Lab Invest, suppl., 220: 47, 1995
10. Nurmikko, P., Pettersson, K., Piironen, T., Hugosson, J. and Lilja, H.: Discrimination of prostate cancer from benign disease by plasma measurement of intact, free prostate-specific antigen lacking an internal cleavage site at Lys145-Lys146. Clin Chem, 47: 1415, 2001
11. Herrala, A., Kurkela, R., Vihinen, M., Kalkkinen, N. and Vihko, P.: Androgen-sensitive human prostate cancer cells, LNCaP, produce both N- terminally mature and truncated prostate-specific antigen isoforms. Eur J Biochem, 255: 329, 1998
12. Shurin, M. R. and Gabrilovich, D. I.: Regulation of dendritic cell system by tumor. Cancer Res Ther Control, 11: 65, 2001
13. Troy, A., Davidson, P., Atkinson, C. and Hart, D.: Renal cell carcinoma and prostate cancer inhibit dendritic cell activation. Aust N Z J Surg, 69: A111, 1999
14. Kennedy-Smith, A. G., McKenzie, J. L., Owen, M. C., Davidson, P. J. T., Vuckovic, S. and Hart, D. N. J.: Prostate specific antigen inhibits immune responses in vitro: a potential role in prostate cancer. J Urol, 168: 741, 2002
15. Shurin, G. V., Shurin, M. R., Bykovskaia, S., Shogan, J., Lotze, M. T. and Barksdale, E. M., Jr.: Neuroblastoma-derived gangliosides inhibit dendritic cell generation and function. Cancer Res, 61: 363, 2001
16. Shurin, M. R., Yurkovetsky, Z. R., Tourkova, I. L., Balkir, L. and Shurin, G. V.: Inhibition of CD40 expression and CD40-mediated dendritic cell function by tumor-derived IL-10. Int J Cancer, 101: 61, 2002
17. Niemela, P., Lovgren, J., Karp, M., Lilja, H. and Pettersson, K.: Sensitive and specific enzymatic assay for the determination of precursor forms of prostate-specific antigen after an activation step. Clin Chem, 48: 1257, 2002
18. Morote, J., Ruibal, A., Pascual, C., Palou, J. and de Torres, J. A.: Bone marrow prostatic specific antigen and prostatic acid phosphatase levels: are they helpful in staging prostatic cancer. J Urol, 137: 891, 1987
19. Jung, K., Brux, B., Lein, M., Rudolph, B., Kristiansen, G., Hauptmann, S. et al: Molecular forms of prostate-specific antigen in malignant and benign prostatic tissue: biochemical and diagnostic implications. Clin Chem, 46: 47, 2000
20. Denmeade, S. R., Sokoll, L. J., Chan, D. W., Khan, S. R. and Isaacs, J. T.: Concentration of enzymatically active prostate-specific antigen (PSA) in the extracellular fluid of primary human prostate cancers and human prostate cancer xenograft models. Prostate, 48: 1, 2001